• <em>Bullosis diabeticorum</em> as a differential diagnosis for limb ulcers: case report
• A patient with concomitant epidermolysis bullosa acquisita, acquired hemophilia and disseminated warts
• A systematic review on efficacy, safety and treatment durability of intravenous immunoglobulin in autoimmune bullous dermatoses: Special focus on indication and combination therapy
• Accuracy of serration pattern analysis by direct immunofluorescence in subepidermal autoimmune blistering diseases
• Acquired epidermolysis bullosa in a pediatric patient
• An uncommon case of epidermolysis bullosa acquisita associated with systemic sclerosis
• Assessing quality of life in patients with autoimmune bullous diseases using the Persian version of Treatment of Autoimmune Bullous Disease Quality of Life questionnaire finds similar effects in women as men
• Autoimmune bullous dermatoses
• Bronchial involvement in mucous membrane pemphigoid: 2 cases and a literature review
• Brunsting-Perry pemphigoid: a systematic review
• Bullous autoimmune dermatoses of the mucous membranes
• Bullous pemphigoid in India: Review of cases registered in an autoimmune bullous disease clinic
• C-type lectin receptor expression is a hallmark of neutrophils infiltrating the skin in epidermolysis bullosa acquisita
• C5aR2 Deficiency Ameliorates Inflammation in Murine Epidermolysis Bullosa Acquisita by Regulating Fcgamma Receptor Expression on Neutrophils
• C5aR2 Deficiency Ameliorates Inflammation in Murine Epidermolysis Bullosa Acquisita by Regulating Fcγ Receptor Expression on Neutrophils
• Case report: A case of epidermolysis bullosa acquisita with IgG and IgM anti-basement membrane zone antibodies relapsed after COVID-19 mRNA vaccination
• Case Report: Biological treatment of epidermolysis bullosa acquisita: report on four cases and literature review
• Case Report: Diagnostic and Therapeutic Challenges in Severe Mechanobullous Epidermolysis Bullosa Acquisita
• Clinical Features of Paediatric Inflammatory Epidermolysis Bullosa Acquisita: A Case Series Study
• Clinical manifestations of alopecia in autoimmune blistering diseases: A cross-sectional study
• Comment on 'Onset of epidermolysis bullosa acquisita under therapy with ustekinumab for the treatment of Crohn disease'
• Corrigendum: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases
• Current and Innovated Managements for Autoimmune Bullous Skin Disorders: An Overview
• Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases
• Direct Immunofluorescence of IgG on Formalin-Fixed Paraffin-Embedded Tissue by Heat-Induced Antigen Retrieval as a Sensitive Method for the Diagnosis of Pemphigus
• Discovering the pathogenesis of autoimmune inflammation
• Eine Patientin mit gleichzeitiger Epidermolysis bullosa acquisita, erworbener Hämophilie und disseminierten Warzen: A patient with concomitant epidermolysis bullosa acquisita, acquired hemophilia and disseminated warts
• Elevated levels of interleukin-9 in the serum of bullous pemphigoid: possible association with the pathogenicity of bullous pemphigoid
• Epidermolysis bullosa acquisita
• Epidermolysis Bullosa Acquisita
• Epidermolysis Bullosa Acquisita
• Epidermolysis bullosa acquisita ausgelost durch Atezolizumab
• Epidermolysis Bullosa Acquisita in a patient with End Stage Renal Disease: Case study
• Epidermolysis bullosa acquisita induced by atezolizumab
• Epidermolysis bullosa acquisita involving the vulva
• Epidermolysis bullosa acquisita mechanica
• Epidermolysis bullosa acquisita treated with ustekinumab: A case report
• Epidermolysis bullosa acquisita with concomitant autoantibodies to alpha3 subunit of laminin 332
• Epidermolysis bullosa acquisita with concomitant autoantibodies to α3 subunit of laminin 332
• Epidermolysis Bullosa Acquisita-Current and Emerging Treatments
• Epidermolysis bullosa acquisita: a case series of three paediatric patients
• Epidermolysis Bullosa Acquisita: A Rare Autoimmune Blistering Disease in Children
• Epidermolysis Bullosa Acquisita: A Report of Four Cases
• Epidermolysis bullosa aquisita following immune-checkpoint inhibitor treatment for metastatic melanoma
• From the Cochrane Library: Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita
• IgM-mediated epidermolysis bullosa acquisita
• IL-10 revisited in systemic lupus erythematosus
• Inflammatory bowel disease and immune-mediated inflammatory diseases: looking at the less frequent associations
• Inhibition of interferon gamma impairs induction of experimental epidermolysis bullosa acquisita
• Intravenous Immunoglobulin for Autoimmune Bullous Diseases: A Case Series from a Central European Referral Center
• Involvement of palms and soles in patients with autoimmune bullous diseases: a comparative analysis of a diagnostically relevant localization
• Luteolin peracetate and gossypolone inhibit immune complex-mediated neutrophil activation <em>in vitro</em> and dermal-epidermal separation in an <em>ex vivo</em> model of epidermolysis bullosa acquisita
• Luteolin peracetate and gossypolone inhibit immune complex-mediated neutrophil activation in vitro and dermal-epidermal separation in an ex vivo model of epidermolysis bullosa acquisita
• Mixed IgM- and IgA-mediated epidermolysis bullosa acquisita associated with IgM-lambda paraproteinemia in an 81-year-old woman
• Mixed IgM- and IgA-mediated epidermolysis bullosa acquisita associated with IgM-λ paraproteinemia in an 81-year-old woman
• Monocyte populations are involved in the pathogenesis of experimental epidermolysis bullosa acquisita
• Natural Occurrence of Autoantibodies against Basement Membrane Proteins in Epidermolysis Bullosa
• Necrotizing fasciitis - a complication of autoimmune skin blistering diseases?
• Neutrophil-Specific Syk Expression Is Crucial for Skin Disease in Experimental Epidermolysis Bullosa Acquisita
• OCULAR INVOLVEMENT IN AUTOIMMUNE BULLOUS DISEASES
• Off-Label Uses of Rituximab in Dermatology
• Onset of epidermolysis bullosa acquisita under therapy with ustekinumab for the treatment of Crohn disease
• Paraneoplastic autoimmune Laminin-332 syndrome (PALS): Anti-Laminin-332 mucous membrane pemphigoid as a prototype
• Pathological Relevance of Anti-Hsp70 IgG Autoantibodies in Epidermolysis Bullosa Acquisita
• Persistence of IgG4 as a potential serological marker of disease activity in patients with epidermolysis bullosa acquisita treated with rituximab
• Potential contribution of anti-p200 autoantibodies to mucosal lesions in anti-p200 pemphigoid
• Protocol to Induce Follicular T Helper Cells, Germinal Centers, and Skin Lesions in Mouse Models for Skin Blistering Diseases
• Pruritogens in pemphigoid diseases: Possible therapeutic targets for a burdensome symptom
• Pruritus Is Associated with an Increased Risk for the Diagnosis of Autoimmune Skin Blistering Diseases: A Propensity-Matched Global Study
• Rare variants of pemphigoid diseases
• Recurrent hemorrhagic bullae of the oral mucosa
• Refractory Epidermolysis Bullosa Acquisita with Chronic Graft-versus-Host Disease Successfully Treated with Rituximab
• Regurgitation and prolapse of oesophageal mucosa: a dramatic presentation of the oesophagitis dissecans superficialis
• Retrospective analysis of autoimmune bullous diseases in Middle Franconia
• Risk factors and sequelae of epidermolysis bullosa acquisita: A propensity-matched global study in 1,344 patients
• Rituximab for the treatment of epidermolysis bullosa acquisita: A large case series of 15 patients
• Rituximab in Subepidermal Blistering Diseases
• Rituximab in the Management of Autoimmune Bullous Diseases: A Treatment-Resistant Case Series from a Single Central European Referral Center
• Rituximab in the Treatment of Epidermolysis Bullosa Acquisita: A Systematic Review
• Rituximab Therapy for Mucous Membrane Pemphigoid: A Retrospective Monocentric Study With Long-Term Follow-Up in 109 Patients
• Rituximab zur Behandlung von Epidermolysis bullosa acquisita: Eine grosse Fallserie mit 15 Patienten
• Role of Human Leukocyte Antigen Class II in Antibody-Mediated Skin Disorders
• Scarring alopecia and nail loss in a patient with epidermolysis bullosa acquisita
• Spontaneous autoimmune subepidermal blistering diseases in animals: a comprehensive review
• State-of-the-art diagnosis of autoimmune blistering diseases
• Subepidermal blistering disease presenting with anti-p200 and anti-type VII collagen autoantibodies
• Subepidermal type VII collagen speckles as an additional clue for diagnosing epidermolysis bullosa acquisita by salt-split skin serum analysis
• Sustained clinical remission for 5 years in severe epidermolysis bullosa acquisita following rituximab infusions
• The association of six autoimmune bullous diseases with thyroid disorders: a population-based study
• The complement receptor C5aR2 regulates neutrophil activation and function contributing to neutrophil-driven epidermolysis bullosa acquisita
• The Immunogenetics of Autoimmune Blistering Diseases
• The Need of Differential Diagnosis Between Vulvar Lichen Sclerosus and Autoimmune Dermatoses in Adolescent Girls
• The pathogeneses of pemphigus and pemphigoid diseases
• The role of C5a receptors in autoimmunity
• Therapeutic effects of Fc gamma RIV inhibition are mediated by selectively blocking immune complex-induced neutrophil activation in epidermolysis bullosa acquisita
• Treatment of Epidermolysis bullosa acquisita with dupilumab
• Treatment of Recurrent Epidermolysis Bullosa Acquisita With Tofacitinib
• U-serrated and n-serrated patterns in bullous pemphigoid, epidermolysis bullosa acquisita, and bullous lupus: A retrospective observational study
• Vesiculobullous Erythema Elevatum Diutinum: a Rare Variant With Epidermolysis Bullosa Acquisita-like Immunofluorescence Findings
• Vesiculobullous Lesions of the Oral Cavity